We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more

Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • Stock information
    • Governance
    • Documentation

Events & presentations

03 Dec 2014

December 3, 2014: Didier Pruneau, CSO of GenSight, featured at Gene Therapy

19 Nov 2014 - 21 Nov 2014

November 19-21, 2014 : GenSight presented at Therapeutic Area Partnership,

23 Jun 2014 - 26 Jun 2014

June 23-26, 2014: GenSight Biologics attended BIO, San Diego, CA, USA

06 Jun 2014

June 6, 2014: GenSight Biologics won the award of the Investor Conference

21 May 2014 - 22 May 2014

May 21-22, 2014: GenSight Biologics presented in the the Next wave Companies

04 May 2014 - 09 May 2014

May 4-9, 2014: GenSight Biologics attended ARVO annual meeting, Orlando, FL, USA

10 Mar 2014 - 12 Mar 2014

March 10-12, 2014: GenSight Biologics presented at BioEurope Spring

28 Feb 2014

February 28, 2014: GenSight Biologics expands its Series A round to the French seed fund

13 Jan 2014 - 16 Jan 2014

January 13-16, 2014: GenSight Biologics attended JP Morgan Healthcare Conference

02 Oct 2013

October 2, 2013: GenSight, EuropaBio’s Top 5 most innovative European biotech in 2013

  • View previous 9 articles
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • View next 9 articles

Stay informed

Subscribe to the newsletter to get the latest GenSight Biologics news

Fields marked with an * are required
© 2019 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
Go back to the page of the page